DEMSER (metyrosine capsules) Patient Assistance Program
Don’t let the high cost of brand metyrosine for pheochromocytoma disrupt your preoperative care. We help eligible patients access Demser (metyrosine capsules) for as little as $69.95 per month through the manufacturer’s Patient Assistance Program.
- Clear & Transparent Pricing
- Paperwork & Doctor-Coordination
- Comprehensive Support: From Application to Entire Journey
- Annual Re-certification And Refills Management
- Medicare Part D Patients Accepted
HIPAA Compliant
BBB Accredited
Secure Website
Key Takeaways:
- Demser (metyrosine) is FDA-approved for the preoperative preparation of patients with pheochromocytoma (a rare catecholamine-secreting adrenal tumor), management of patients when surgery is contraindicated, and long-term management when surgery cannot be performed. Tyrosine hydroxylase inhibitor — blocks the rate-limiting step in catecholamine synthesis, reducing tumor catecholamine output and stabilizing blood pressure preoperatively.
- Without assistance, brand Demser costs commonly run approximately $1,500–$2,500 per 30-day supply.
- Through AffordMyPrescriptions, qualifying patients can access Demser for a flat $69.95 per month.
- Standard preoperative pheochromocytoma management typically involves alpha-blockade with phenoxybenzamine (Dibenzyline — limited generic availability) or generic selective alpha-1 blockers (doxazosin, prazosin, terazosin) for 7–14 days before surgery, followed by beta-blocker addition only after adequate alpha-blockade (never before — risk of hypertensive crisis). Calcium channel blockers (nifedipine, amlodipine) are alternatives. Metyrosine (Demser) is added for refractory hypertension, very large tumors, or extensive metastatic disease. Definitive treatment is surgical resection (open or laparoscopic adrenalectomy). For metastatic pheochromocytoma: I-131 MIBG (Azedra), targeted therapies (sunitinib, cabozantinib), peptide receptor radionuclide therapy (Lutathera for SSTR-positive tumors), chemotherapy (CVD regimen).
What is DEMSER Prescription Assistance Program?
The Demser Patient Assistance Program is a manufacturer-sponsored initiative that helps eligible patients access Demser (used for preoperative preparation of pheochromocytoma and management when surgery is not feasible) at little or no cost when they meet specific income, insurance, and clinical criteria. The program is free to apply for, but the enrollment process involves detailed applications, endocrinology and surgical oncology coordination, extensive documentation of pheochromocytoma diagnosis and preoperative protocol, and ongoing renewal — which can be overwhelming when you are facing a rare catecholamine-secreting tumor.
At AffordMyPrescriptions, our Patient Advocates handle the entire Demser PAP enrollment for a flat $69.95 per month. We complete the application, coordinate with your endocrinologist and surgeon for required medical documentation (typically including biochemical confirmation of pheochromocytoma, imaging, and preoperative protocol), follow up with the manufacturer’s program until approval, manage your refills, and handle annual re-certification — so you never face a gap in your Demser pheochromocytoma therapy.
AffordMyPrescriptions eliminates that burden. For a flat $69.95 per month, our Patient Advocates handle every step of your Demser enrollment — from the initial application through ongoing refills and annual re-enrollment — so you never face a gap in your pheochromocytoma treatment.
Pharmacy Price Comparison
- Without assistance, Demser costs thousands of dollars per month for a rare-disease medication at retail and specialty pharmacies. Discount cards and pharmacy coupons offer minimal relief, but a Patient Assistance Program can make this rare-disease therapy accessible if you qualify. The table below compares typical retail pricing across major pharmacies to what you'd pay with our Demser advocacy service:
| Pharmacy(With Coupon) | PrIce (30-Day)* | You Save W/ Us |
|---|---|---|
| Walgreens | ~$2,400/mo | Save substantially |
| CVS Pharmacy | ~$2,500/mo | Save substantially |
| Walmart | ~$1,800/mo | Save substantially |
| Costco | ~$1,500/mo | Save substantially |
| Generic alpha-blockers (alt) | ~$15/mo | Generic preop alt |
*Retail prices are estimates based on public data and vary by pharmacy. Coupon prices from GoodRx and SingleCare as of April 2026. AffordMyPrescriptions Advocacy Service bypasses pharmacy pricing entirely by using the manufacturer’s assistance program to secure your Demser — independent of dosage or retail price.
Our Pricing:
$69.95 Per month
1 Medications
$79.95 Per Month
2 Medications
$89.95 Per Month
3 Medications
$99.95 Per Month
4+ Medications
Why choose us For Your Demser Prescription Program?
The Demser Patient Assistance Program is free to apply and provides medication at no cost if approved. But the process involves detailed applications, prescriber coordination, documentation, and ongoing management — applications that are commonly delayed or denied when paperwork is incomplete. Our $69.95 per month covers full advocacy: applications, doctor coordination, documentation, refill management, and re-enrollment — so you focus on your health, not paperwork. Standard preoperative pheochromocytoma management uses phenoxybenzamine or selective alpha-1 blockers; Demser is added for refractory hypertension, very large tumors, or extensive metastatic disease.
Enroll
Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.
We Advocate
Our specialists help gather documentation, complete applications, and coordinate with program providers.
Receive Medication
Once approved, you may receive your medication through the assistance program while we help manage ongoing paperwork and renewals.
Discount Coupons vs. Patient Assistance Programs
Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for Demser:
Limitations of Coupons
- Prices fluctuate — savings aren’t guaranteed month-to-month
- Copay accumulators may prevent savings from counting toward deductible
Coupon cards expire and require constant renewal
Still $1,500–$2,500 per month even with the best discount
- Can’t be used with Medicare, Medicaid, or government insurance
Advantages of PAP Through Us
- Fixed $69.95/month — never changes regardless of retail price
- No expiration — continuous access as long as you qualify
- Medication supplied directly from the manufacturer
- We manage all paperwork, refills, and renewals
- If denied, we explore alternative savings on your behalf
DO YOU QUALIFY?
Eligibility is generally determined by annual household income levels. Most programs follow guidelines that include a limit of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because these requirements can vary, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation and determine if you qualify for assistance.
- You are a U.S. citizen or legal resident
- You Have A Valid Demser Prescription From A Licensed U.S. Healthcare Provider
- You Are Uninsured, Underinsured, Or A Medicare Part D Beneficiary
- You Have Recently Experienced A Change In Financial Circumstances That Affects Your Ability To Pay
Understanding Demser:
Brand Demser $1,500–$2,500 per month. As a rare-disease medication, Demser has no generic. Standard alpha-blocker preparation (phenoxybenzamine or generic selective alpha-1 blockers) is less expensive.
FAQ (Frequently Asked Questions)
How Much Does Demser Cost Without Insurance?
Brand Demser $1,500–$2,500 per month. As a rare-disease medication, Demser has no generic. Standard alpha-blocker preparation (phenoxybenzamine or generic selective alpha-1 blockers) is less expensive
What is pheochromocytoma and how does Demser help?
Pheochromocytoma is a rare catecholamine-secreting tumor of the adrenal medulla (paraganglioma is the extra-adrenal counterpart) causing uncontrolled hypertension and symptoms from excess adrenaline. Demser blocks the rate-limiting enzyme in catecholamine synthesis — reducing tumor hormone output — making blood pressure more stable for surgery. Definitive treatment is surgical resection.
Is Demser the standard preoperative therapy for pheochromocytoma?
No — the standard preoperative protocol uses alpha-blockade (phenoxybenzamine or selective alpha-1 blockers) for 7–14 days before surgery, with addition of beta-blocker only after adequate alpha-blockade. Demser is added for refractory hypertension, very large tumors, or extensive metastatic disease where alpha-blockade alone is insufficient.
Why must alpha-blockers be started before beta-blockers in pheochromocytoma?
Unopposed alpha-adrenergic stimulation from a beta-blocker (which blocks beta-mediated vasodilation) can cause severe hypertensive crisis in pheochromocytoma. Alpha-blockade must be established first to allow safe beta-blocker addition for tachycardia or arrhythmia management.
What are the most common side effects of Demser?
Sedation (very common — often requires dose reduction or limits use), diarrhea (sometimes severe), extrapyramidal symptoms (parkinsonism, dystonia — rare but reportable), psychic disturbances (depression, anxiety, hallucinations — rare), crystalluria (maintain hydration ≥2,500 mL/day), hypersensitivity. Many patients tolerate metyrosine poorly long-term.
How does Demser work compared to alpha-blockers?
Alpha-blockers (phenoxybenzamine, doxazosin) block the alpha-adrenergic receptors that mediate catecholamine-induced vasoconstriction — preventing the cardiovascular effects. Metyrosine (Demser) acts upstream — reducing the production of catecholamines by the tumor itself. The two mechanisms are complementary and often combined for complex cases.
What happens if my Demser Patient Assistance Program application is denied?
We help explore phenoxybenzamine (Dibenzyline — standard alpha-blocker preoperative therapy), generic selective alpha-1 blockers (doxazosin, prazosin — much cheaper), beta-blocker addition after adequate alpha-blockade, calcium channel blockers, pheochromocytoma Center of Excellence consultation, rare disease foundations (Pheo Para Alliance, NORD), Patient Advocate Foundation, NeedyMeds, and surgical oncology referral for definitive resection.
Take Control of Your Medication Costs
Rare pheochromocytoma preoperative management should not be derailed by cost. Standard alpha-blockade and surgical preparation pathways remain available. Our Demser advocacy team is ready to verify your eligibility, complete the manufacturer application on your behalf, and manage your prescription through approval, delivery, and renewal — for a flat $69.95 per month. If we cannot help you access Demser through a Patient Assistance Program, you are not charged. Call (833) 556-2729 or check your eligibility online today.
Submit Enrollment Form
Start free by filling out a simple online form.
Receive Welcome Call
Our specialist will contact you for a quick welcome call.
We Manage The Process
Our team handles everything, so you can focus on your health.